Morgan Stanley
LABX

Morgan Stanley’s Tradr 2X Long ALAB Daily ETF LABX Stock Holding History

Morgan Stanley’s Portfolio LABX Stock Details LABX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716 Buy
+288
New +$1.49K ﹤0.01% 7532

Other funds holding LABX

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley's LABX Position: Q1 2026 in Review

Morgan Stanley opened a new position in Tradr 2X Long ALAB Daily ETF (LABX) in Q1 2026: 288 shares worth $716. The stake represents ﹤0.01% of the portfolio and ranks #7532 among its holdings.

6 funds tracked by Wall St. Rank hold LABX as of Q1 2026.

  • Morgan Stanley held 288 shares of Tradr 2X Long ALAB Daily ETF worth $716 as of Q1 2026.
  • Tradr 2X Long ALAB Daily ETF was a new Morgan Stanley position in Q1 2026.
  • Tradr 2X Long ALAB Daily ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7532 holding.
  • 6 funds tracked by Wall St. Rank held Tradr 2X Long ALAB Daily ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.